Cargando…

SERCA2a: a prime target for modulation of cardiac contractility during heart failure

Heart failure is one of the leading causes of sudden death in developed countries. While current therapies are mostly aimed at mitigating associated symptoms, novel therapies targeting the subcellular mechanisms underlying heart failure are emerging. Failing hearts are characterized by reduced contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Woo Jin, Oh, Jae Gyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Biochemistry and Molecular Biology 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133892/ https://www.ncbi.nlm.nih.gov/pubmed/23710633 http://dx.doi.org/10.5483/BMBRep.2013.46.5.077

Ejemplares similares

SUMO1-dependent modulation of SERCA2a in heart failure
por: Kho, Changwon, et al.
Publicado: (2011)

Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure
por: Kho, Changwon, et al.
Publicado: (2015)

Contractile Behavior of Mouse Aorta Depends on SERCA2 Isoform Distribution: Effects of Replacing SERCA2a by SERCA2b
por: Fransen, Paul, et al.
Publicado: (2020)

Cardiac Plin5 interacts with SERCA2 and promotes calcium handling and cardiomyocyte contractility
por: Cinato, Mathieu, et al.
Publicado: (2023)

Cardiac contractility modulation: a novel approach for the treatment of heart failure
por: Abi-Samra, Freddy, et al.
Publicado: (2016)

miR-132/212 Impairs Cardiomyocytes Contractility in the Failing Heart by Suppressing SERCA2a
por: Lei, Zhiyong, et al.
Publicado: (2021)

Identification and Characterization of p300-Mediated Lysine Residues in Cardiac SERCA2a
por: Gorski, Przemek A., et al.
Publicado: (2023)

A Decoy Peptide Targeted to Protein Phosphatase 1 Attenuates Degradation of SERCA2a in Vascular Smooth Muscle Cells
por: Jang, Seung Pil, et al.
Publicado: (2016)

SERCA2a Protein Levels Are Unaltered in Human Heart Failure
por: Ragone, Isabella, et al.
Publicado: (2023)

New Generation Cardiac Contractility Modulation Device—Filling the Gap in Heart Failure Treatment
por: Tint, Diana, et al.
Publicado: (2019)

Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond
por: Tschöpe, Carsten, et al.
Publicado: (2018)

Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function
por: Tschöpe, Carsten, et al.
Publicado: (2020)

Cost‐effectiveness of a cardiac contractility modulation device in heart failure with normal QRS duration
por: Witte, Klaus, et al.
Publicado: (2020)

Septal myocardial scar burden predicts the response to cardiac contractility modulation in patients with heart failure
por: Ansari, Uzair, et al.
Publicado: (2022)

Cardiac contractility modulation attenuates structural and electrical remodeling in a chronic heart failure rabbit model
por: Ning, Bin, et al.
Publicado: (2020)

CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensors
por: Manfra, Ornella, et al.
Publicado: (2021)

Use of Cardiac Contractility Modulation as Bridge to Transplant in an Obese Patient With Advanced Heart Failure: A Case Report
por: Masarone, Daniele, et al.
Publicado: (2022)

SERCA is critical to control the Bowditch effect in the heart
por: Balcazar, Darío, et al.
Publicado: (2018)

The effects of buthionine sulfoximine treatment on diaphragm contractility and SERCA pump function in adult and middle aged rats
por: Smith, Ian C, et al.
Publicado: (2015)

Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy
por: Samuel, T. Jake, et al.
Publicado: (2018)

Differential Modulation of SERCA2 Isoforms by Calreticulin
por: John, Linu M., et al.
Publicado: (1998)

Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment Contractility
por: Maning, Jennifer, et al.
Publicado: (2022)

Effect of Bortezomib on the Efficacy of AAV9.SERCA2a Treatment to Preserve Cardiac Function in a Rat Pressure-Overload Model of Heart Failure
por: Chaanine, Antoine H., et al.
Publicado: (2014)

Hydrogen Sulfide Regulates SERCA2a Ubiquitylation via Muscle RING Finger-1 S-Sulfhydration to Affect Cardiac Contractility in db/db Mice
por: Peng, Shuo, et al.
Publicado: (2022)

Modulation of myosin by cardiac myosin binding protein-C peptides improves cardiac contractility in ex-vivo experimental heart failure models
por: Hou, Luqia, et al.
Publicado: (2022)

Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support
por: Ezzitouny, Meryem, et al.
Publicado: (2021)

Cardiac contractility modulation therapy: Are there superresponders?
por: Al-Ghamdi, Bandar, et al.
Publicado: (2017)

Inhibition of miR-25 Improves Cardiac Contractility in the Failing Heart
por: Wahlquist, Christine, et al.
Publicado: (2014)

Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice
por: Dhondup, Yangchen, et al.
Publicado: (2017)

Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device – the SERCA-LVAD TRIAL
por: Lyon, A. R., et al.
Publicado: (2020)

Cardiac Contractility Modulation Attenuates Chronic Heart Failure in a Rabbit Model via the PI3K/AKT Pathway
por: Hao, Qingqing, et al.
Publicado: (2020)

Effects of Cardiac Contractility Modulation Electrodes on Tricuspid Regurgitation in Patients with Heart Failure with Reduced Ejection Fraction: A Pilot Study
por: Masarone, Daniele, et al.
Publicado: (2022)

Targeting oncogenic Notch signaling with SERCA inhibitors
por: Pagliaro, Luca, et al.
Publicado: (2021)

Increased SERCA2a sub-cellular heterogeneity in right-ventricular heart failure inhibits excitation-contraction coupling and modulates arrhythmogenic dynamics
por: Holmes, M., et al.
Publicado: (2022)

Cardiac Contractility Modulation: A Technical Review
por: Hesselson, Aaron B.
Publicado: (2022)

Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression
por: Røe, Åsmund T, et al.
Publicado: (2019)

Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction
por: Müller, D., et al.
Publicado: (2017)

Long‐term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction
por: Röger, Susanne, et al.
Publicado: (2018)

SERCA2 Haploinsufficiency in a Mouse Model of Darier Disease Causes a Selective Predisposition to Heart Failure
por: Prasad, Vikram, et al.
Publicado: (2015)

Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice
por: Dhondup, Yangchen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_65icc2dtip7u8cg0e88gnrob65